These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-001538-18 A randomised, double blinded, placebo controlled multicentre study for the efficacy and safety of Depigoid birch pollen 2006-08-24 due-trials
Ongoing 2004-001965-16 ENSAYO CLÍNICO, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO CONTROLADO CON PLACEBO, DE INMUNOTERAPIA SUBLINGUAL CON EXTRACTO ALERGÉNICO DE DERMATOPHAGOIDES PTERONYSSINUS EN PACIENTES CON ASMA, DE INTENSI... not-yet-due
Ongoing 2004-001966-41 ENSAYO CLÍNICO, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO CONTROLADO CON PLACEBO, DE INMUNOTERAPIA SUBLINGUAL CON EXTRACTO DE POLEN DE PHLEUM PRATENSE EN PACIENTES CON HIPERSENSIBILIDAD AL POLEN DE GRA... not-yet-due
Ongoing 2005-001194-96 Extracto alergénico de Chortoglyphus arcuatus. Determinación de la potencia alergénica in vivo en unidades equivalentes de histamina (HEP) not-yet-due
Completed, but no date, and reported results 2005-001584-66 A randomised controlled multicentre study for the safety of Depigoid(R) rush schedule bad-data
Completed, but no date, and reported results 2005-001880-68 Standardization of Latex allergenic extract. Determination of biological activity in HEP units bad-data
Ongoing 2006-000571-15 Extracto alergénico despigmentado polimerizado de Dermatophagoides pteronyssinus como tratamiento antiasmático en niños con asma leve alérgicos a ácaros. not-yet-due
Other 2006-000602-23 A randomized double blind, placebo controlled study to evaluate the efficacy and security of immunotherapy with a depigmented and polymerized allergen extract of Dermatophagoides pteronyssinus in pati... not-yet-due
Not reported 2006-001130-41 Ensayo clínico prospectivo, randomizado, doble ciego, paralelo, controlado frente a placebo de inmunoterapia sublingual con extracto alergénico despigmentado y polimerizado con glutaraldehído de Olea ... 2009-09-30 due-trials
Not reported 2006-001437-18 Inmunoterapia con extracto alergénico despigmentado y polimerizado con glutaraldehído de Phleum pratense, en pacientes afectos de rinoconjuntivitis y/o asma alérgicos 2009-09-24 due-trials
Reported results 2006-003065-14 Investigation of a preseasonal rush treatment scheme with Depigoid® Grass Mix as an add-on therapy in patients with allergic rhinitis and/or rhinoconjunctivitis sensitized to grass pollen 2009-09-24 due-trials
Reported results 2006-003066-34 A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® House dust mites (HDM) in patients suf-fering from moderate to severe atopic eczema. 2010-07-02 due-trials
Reported results 2006-003067-31 A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree pollen 2008-08-05 due-trials
Ongoing, reported early 2006-003408-20 Extracto alergénico de Salsola oppositifolia Determinación de la potencia alergénica in vivo en unidades equivalentes de histamina (HEP) not-yet-due
Completed, but no date, and reported results 2006-005269-20 Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of Depigoid® Grass Mix as a rush immunotherapy in patients with allergic rhinitis using an environmental exp... bad-data
Ongoing 2006-005727-41 Ensayo clínico, multicéntrico, aleatorizado, doble ciego controlado con placebo, de inmunoterapia subcutánea con extracto despigmentado y polimerizado de polen de Olea europaea en pacientes con hipers... not-yet-due
Listed as ongoing, but also has a completion date 2006-005868-10 Ensayo clínico, multicéntrico, aleatorizado, doble ciego controlado con placebo, de inmunoterapia subcutánea con extracto despigmentado y polimerizado de polen de Phleum pratense en pacientes con hipe... 2013-01-28 bad-data
Completed, but no date 2006-005871-17 Ensayo clínico, multicéntrico, aleatorizado, doble ciego controlado con placebo, de inmunoterapia subcutánea con extracto despigmentado y polimerizado de polen de Parietaria judaica en pacientes con h... bad-data
Ongoing, reported early 2007-000904-33 Extracto alergénico de Glycyphagus domesticus. Determinación de la potencia alergénica in vivo en unidades equivalentes de histamina (HEP) not-yet-due
Reported results 2007-004255-10 Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Depigoid® Grass Mix in patients with al-lergic rhinitis and/or rhinoconjunctivitis with or wit... 2008-09-22 due-trials
Reported results 2007-004876-38 An open label multicenter phase 2 study for the initial evaluation of the tolerability of Birch pollen extract in patients suffering from atopic eczema and clinical relevant IgE-mediated sensitization... 2009-01-06 due-trials
Reported results 2008-002264-34 Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid® Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with o... 2010-10-05 due-trials
Reported results 2008-008448-26 Randomized, double-blind, parallel group, multicenter study to evaluate the efficacy and safety of four doses of depigmented glutaraldehyde polymerized birch pollen allergenic extract (Depigoid® Birch... 2011-03-24 due-trials
Ongoing 2010-018562-23 A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients with Allergic Rhinitis and/or Rhinoconjunctivitis... not-yet-due
Completed, but no date 2010-019355-22 Ensayo Clínico multicéntrico, doble ciego, para la comparación in vivo del tamaño de las pápulas cutáneas producidas por los extractos alergénicos nativo, despigmentado y despigmentado polimerizado d... bad-data
Completed, but no date, and reported results 2010-023948-33 Estandarización biológica del extracto alergénico de Dactylis glomerata para determinar la actividad biológica en unidades equivalentes de Histamina (HEP). bad-data
Ongoing, reported early 2010-023949-29 Estandarización biológica del extracto alergénico de Lolium perenne para determinar la actividad biológica en unidades equivalentes de Histamina(HEP). not-yet-due
Completed, but no date, and reported results 2010-023950-35 Biological standardization of Poa pratensis allergen extract to determine the biological activity in HEP units. bad-data
Completed, but no date, and reported results 2010-023951-27 Estandarización biológica del extracto alergénico de Secale cereale para determinar la actividad biológica en unidades equivalentes de Histamina (HEP). bad-data
Completed, but no date Terminated 2011-000870-79 Prospective study to evaluate the safety of a 4-month treatment with Depigoid® Dermatophagoides pteronyssinus or 50% Dermatophagoides pteronyssinus / 50% Dermatophagoides farinae (500 DPP/ml) in patie... bad-data
Reported results 2011-002096-42 Biological Standardization of Ambrosia elatior Allergen Extract Determination of the Biological Activity in HEP units. An Open Monocenter Study. 2013-12-17 due-trials
Ongoing, reported early 2011-003634-14 Estandarización biológica del extracto alergénico de Blomia tropicalis para determinar la actividad biológica en unidades equivalentes de Histamina (HEP). not-yet-due
Completed, report not yet due 2012-000414-11 Multicenter, placebo-controlled, long-term study of Depigoid Birch 5000 in adults and adolescents with allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma 2018-07-30 not-yet-due
Reported results 2012-000416-28 A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum in Patients with Allergic Rhinitis and/or Rhinoconjunctivitis... 2013-07-31 due-trials
Ongoing 2012-001699-12 Prospective, open uncontrolled study to evaluate the safety of Depigoid with two pollen combinations ( Grasses/Olea and Grasses/ Parietaria) 2000 DPP/ml in patients with allergic rhinitis or rhinoconj... not-yet-due
Ongoing 2012-001931-30 Ensayo Clínico multicéntrico, abierto, para la comparación de la potencia biológica entre los extractos alergénicos nativo, despigmentado y despigmentado-polimerizado de epitelio de gato. not-yet-due
Completed, but no date 2012-001937-15 Biological standardization of Chenopodium album allergen extract to determine the biological activity in HEP units. bad-data
Ongoing 2012-001938-34 Biological standardization of Platanus acerifolia allergen extract to determine the biological activity in HEP units. not-yet-due
Completed, but no date, and reported results 2012-001939-31 Biological standardization of Dermatophagoides pteronyssinus allergen extract to determine the biological activity in histamine equivalent units (HEP). bad-data
Completed, but no date 2013-001308-13 Biological standardization of Alternaria alternata allergen extract to determine the biological activity in histamine equivalent units (HEP). bad-data
Completed, but no date 2013-001309-98 Biological standarization of Cupressus arizonica allergen extract to determine the biological activity in histamine equivalent units (HEP) bad-data
Completed, but no date 2013-001310-15 Biological standardization of Artemisia vulgaris allergen extract to determine the biological activity in histamine equivalent units (HEP). bad-data
Not reported 2013-004920-12 Non-interventional Study in Allergic Patients Suffering from Grass Pollen Induced Rhinitis/Rhinoconjunctivitis with or without Asthma. 2014-03-02 due-trials
Completed, but no date 2014-000172-26 A multicentre, open label, phase IIb clinical trial to evaluate safety, tolerability and efficacy of the depigmented modified allergen extract of two mites mixes at 200 DPP/ml (DP/MG/14-1 Dermatophago... bad-data
Not reported Terminated 2014-001571-31 A randomized (open-label design), parallel group, multicentre study to evaluate the safety and tolerability of two different doses of Depigoid 34% GrassesMix, 33% Olea europaea and 33% Salsola kali a ... 2015-06-22 due-trials
Reported results 2014-004732-19 A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum versus Placebo in Patients with Allergic Rhinitis and/or Rhin... 2016-05-13 due-trials